COMMUNIQUÉS West-GlobeNewswire

Phoenix Life Sciences International Announces Michael Gobel as Finance Advisor
27/02/2019
DENVER, CO, Feb. 27, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Phoenix Life Sciences International Limited (OTC: PLSI) (“Phoenix Life”), an international adaptive healthcare solutions company, today announced that [...]
Evolus Appoints Crystal Muilenburg as Vice President Corporate Communications & Public Relations
27/02/2019
NEWPORT BEACH, Calif., Feb. 27, 2019 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company focused on delivering breakthrough products, today announced the appointment of Crystal Muilenburg as [...]
Agritek Holdings, Inc. Announces CEO Webcast Interview with Uptick Newswire Discussing Expansion Into Cannabis Edibles and Beverages in Multiple Regulated Jurisdictions
27/02/2019
LOS ANGELES, CA, Feb. 27, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Agritek Holdings, Inc. (OTC PINK: AGTK) www.AgritekHoldings.com , a fully integrated, active cannabis real estate investor and brand licensor for the [...]
Obalon Announces First Commercial Use of Navigation and Touch Products for Obalon Balloon Administration
27/02/2019
SAN DIEGO, Feb. 27, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN ) announces the first commercial use of the Obalon Navigation System™ and Touch™ Inflation Dispenser for balloon administration. The [...]
Sarepta Therapeutics Announces Positive and Robust Expression and Biomarker Data from the First Three-Patient Cohort Dosed in the MYO-101 Gene Therapy Trial to Treat Limb-Girdle Muscular Dystrophy Type 2E, or Beta-Sarcoglycanopathy
27/02/2019
-- In two-month post-treatment muscle biopsies, clinical trial participants showed a mean of 51% beta-sarcoglycan (beta-SG) positive fibers, as measured by immunohistochemistry (IHC), substantially exceeding the pre- [...]
Kamada Files Annual Report for the Year Ended December 31, 2018
27/02/2019
REHOVOT, Israel, Feb. 27, 2019 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ & TASE: KMDA), a plasma-derived protein therapeutics company, today announced that it has filed its annual report on Form 20-F for the fiscal [...]
Canopy Rivers Completes Previously Announced Bought Deal and Concurrent Private Placement for Total Gross Proceeds of Approximately $93.5 Million
27/02/2019
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Feb. 27, 2019 (GLOBE NEWSWIRE) -- Canopy Rivers Inc. (TSXV:RIV) (“ Canopy Rivers ” or the “ Company ”) is [...]
CV Sciences, Inc. to Present and Exhibit at Natural Products Expo West 2019 in Anaheim, California, March 5-9, 2019
27/02/2019
Company enters its 4 th year exhibiting at the nation's largest natural products trade show, offering natural health retailers show specials, one-on-one education, and a wide selection of product offerings. LAS VEGAS, [...]
Precision Therapeutics Inc. Announces Pricing of Public Offering of Up to $1.26 Million of Units
27/02/2019
MINNEAPOLIS, Feb. 27, 2019 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”) today announced the pricing of its previously announced public offering of its common stock and [...]
Albireo to Report Year-End 2018 Financial Results and Host Conference Call and Webcast on March 7, 2019
27/02/2019
BOSTON, Feb. 27, 2019 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced that management will host a [...]
Evoke Pharma Schedules Conference Call and Webcast for Fourth Quarter and Full-Year 2018 Financial Results
27/02/2019
SOLANA BEACH, Calif., Feb. 27, 2019 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that the Company [...]
Hemispherx Biopharma Updates the Terms of Previously Announced Rights Offering and Announces Senior Management and Directors All Plan to Participate in the Offering
27/02/2019
OCALA, Fla., Feb. 27, 2019 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American: HEB) (“Hemispherx” or the “Company”), an immuno-pharma R&D and emerging commercial growth company focused on unmet medical [...]
The State of Illinois Teams Up with Helix TCS to Take on the Opioid Epidemic -- CFN Media
27/02/2019
Seattle, WA, Feb. 27, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication [...]
Nanogen Launch Brings Revolutionary Cannabis and Hemp Nano Emulsions to Mainstream Food, Beverage, Health and Beauty Markets
27/02/2019
New nano-emulsion technology company takes oil from plants, makes it customizable and scalable for easy and cost-effective entry into existing supply chains OAKLAND, Calif., Feb. 27, 2019 (GLOBE NEWSWIRE) -- Nanogen [...]
Helsinn Investment Fund: Ten finalists have been chosen for the second annual Lyfebulb-Helsinn Innovation Summit & Awards in Oncology
27/02/2019
Ten finalists have been chosen for the second annual Lyfebulb-Helsinn Innovation Summit & Awards in Oncology The Award recognizes Patient Entrepreneurs’ innovations for cancer and cancer supportive care using [...]
Notice to convene Annual General Meeting 2019 of GN Store Nord
27/02/2019
Please find enclosed notice of GN Store Nord A/S’ Annual General Meeting 2019, including the complete proposals for the agenda For further information, please contact: Investors and analysts Peter Justesen VP – Investor [...]
Progressive Care Inc. Subsidiary PharmCo, LLC Earns Top Performance Scores From Humana Inc.
27/02/2019
MIAMI, Feb. 27, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announced that its wholly owned subsidiary PharmCo, LLC has met all three [...]
Milestone Scientific’s Director of Clinical Affairs Interviewed on Proactiveinvestors.com
27/02/2019
LIVINGSTON, N.J., Feb. 27, 2019 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS) , a leading developer of computerized drug instruments that provide painless and precise injections, today announced that Dr. [...]
Foamix Announces Positive Results from Phase 3 Open-Label Safety Study Evaluating FMX103 Topical Minocycline Foam for Treatment up to 1 Year
27/02/2019
Long Term Data on FMX103 Demonstrated a Generally Favorable Safety Profile; 81.6% of Patients Achieved Clear or Almost Clear Skin at 52 Weeks REHOVOT, Israel and BRIDGEWATER, N.J., Feb. 27, 2019 (GLOBE NEWSWIRE) -- [...]

Pages